Advertisement

Growth Out of Control

Abstract

Since 1948,the early detection of cancer has been a major goal of nuclear medicine.The direction of research has been to develop tracers that accumulate in cancer cells because of their biochemical or immunological properties.Another approach has been to detect cancerous lesions because they produce defects in normal processes,such as phagocytosis in the liver or regional blood flow in the lung.In 1975,among the first agents was selenium-75 selenomethionine,an amino acid that accumulates during the process of protein synthesis.This tracer did not achieve widespread clinical use because of the high body background and slow accumulation in the lesions.The same was true for iodine-125-iodoquine,a chloroquine analogue,and indium-111 or cobalt-57 bleomycin,all developed in 1975.

Keywords

Thyroid Cancer Bone Metastasis Cancerous Lesion Detect Bone Metastasis Positron Emission Tomo 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Copyright information

© Springer-Verlag London Limited 2006

Personalised recommendations